Clinical Trial Update: Apply the PD Model of Peripheral Oxytocin Action to a Multimodal Stimulus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial involving oxytocin's peripheral action in response to a multimodal stimulus was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Pain, Chronic | Phase 2 | Status: WITHDRAWN